Leukopaks®, Fresh
$910
In stock
SKU
Category: Research Products
Product Description
Leukopaks® are collected from healthy human donors, tested negative for HBV, HCV, and HIV, using the Spectra Optia® Apheresis System, where cell-rich mononuclear cells are extracted using a continuous flow method directly into a sterile collection bag containing the anticoagulant ACD-A. Additionally, 200-300mL of plasma can be collected at the time of the donor draw. Up to 12 Leukopak collections can be performed on the same donor in a given year, providing an ample amount of PBMCs for large-scale experiments and research studies.
• Enriched PBMCs
• 0.1-0.2% CD34+ cells
• Low hematocrit
• Low granulocytes
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Custom Orders
We work closely with our customers to provide them with the product they need. For a custom order, please call and speak to one of our sales specialists at 530-303-3828.
| Species | Human |
|---|---|
| Disease State | Healthy |
| Cell and Tissue Source | Peripheral Blood |
| Product Type | Whole |
| Cell Type | Mononuclear Cells |
| Donor Attributes | HIV-, HepB-, HepC- |
| Viability | ≥90% by Flow Cytometry |
| Format | Fresh |
| Anticoagulant | ACD-A |
Product Information Sheet
Certificate of Analysis
Material Safety Data Sheet
Figure 1. Representative flow analysis of a peripheral blood Leukopak after RBC lysis.
Customers Also Viewed:
